EquityPandit’s Outlook for Sun Pharma for the week (February 20, 2017 – February 24, 2017) :

SUN PHARMA:

SUN PHARMA closed the week on positive note gaining around 3.00%.

As we have mentioned last week that minor support for the stock lies in the zone of 645 to 650. Support for the stock lies in the zone of 620 to 625 where the stock has taken multiple support. If the stock manages to close below these levels then the stock can drift to the levels of 600 to 610. During the week the stock manages to hit a low of 621 and close the week around the levels of 675.

Minor support for the stock lies in the zone of 650 to 655. Support for the stock lies in the zone of 620 to 625 where the stock has taken multiple support. If the stock manages to close below these levels then the stock can drift to the levels of 600 to 610.

Resistance for the stock lies in the zone of 670 to 675 from where the stock sold off on 15/12/2016. If the stock manages to close above these levels then the stock can move to the levels of 690 to 700 from where the stock sold off on 07/12/2016.

Broad range for the stock in the coming week can be 650 – 655 on lower side & 695 – 700 on upper side.